SRNE - Sorrento Therapeutics subsidiary Scilex not a part of Chapter 11 bankruptcy filing
- Scilex Holding Co. ( NASDAQ: SCLX ), a majority-owned subsidiary of Sorrento Therapeutics ( NASDAQ: SRNE ), is not a debtor in the latter's Chapter 11 bankruptcy filing announced earlier on Monday.
- The two companies said that business will continue as usual at Scilex ( SCLX ).
- Sorrento closed down ~73% , while Scilex ( SCLX ) lost ~26% .
- In late January, Seeking Alpha contributor Edmund Ingham called Scilex ( SCLX ) a sell.
For further details see:
Sorrento Therapeutics subsidiary Scilex not a part of Chapter 11 bankruptcy filing